<DOC>
	<DOCNO>NCT00005842</DOCNO>
	<brief_summary>Phase I trial study effectiveness trastuzumab plus R115777 treat patient advanced metastatic cancer . Monoclonal antibody trastuzumab locate tumor cell either kill deliver tumor-killing substance without harm normal cell . Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining trastuzumab R115777 may kill tumor cell .</brief_summary>
	<brief_title>Trastuzumab Plus R115777 Treating Patients With Advanced Metastatic Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine maximum tolerate dose R115777 administer trastuzumab ( Herceptin ) patient advance metastatic adenocarcinoma . II . Assess toxicities pharmacokinetics treatment regimen patient population . III . Determine antitumor activity treatment regimen patient . IV . Determine relative biologic endpoint regimen correlate toxicity pharmacokinetic parameter patient . OUTLINE : This dose escalation , multicenter study R115777 . Patients receive trastuzumab ( Herceptin ) IV 90 minute day 1 , 8 , 15 , 22 plus oral R115777 twice daily 3 week . Treatment continue every 28 day absence disease progression unacceptable toxicity . Cohorts 3-6 patient receive escalate dos R115777 maximum tolerate dose ( MTD ) determine . The MTD define dose 1 6 patient experience dose limit toxicity . Patients follow every 30 day toxicity resolve .</detailed_description>
	<mesh_term>Tipifarnib</mesh_term>
	<mesh_term>Trastuzumab</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm advanced metastatic adenocarcinoma Expression +1 3+ HER2/neu immunohistochemical immunocytochemistry stain No brain metastasis unless follow true : Previously treat Asymptomatic Stable dose decadron No evidence edema PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Life expectancy : At least 12 week Absolute granulocyte count least 1,500/mm3 Platelet count least 100,000/mm3 Hemoglobin least 9.0 g/dL Bilirubin great 1.5 mg/dL AST/ALT great 3 time upper limit normal ( ULN ) ( great 5 time ULN case liver involvement ) Creatinine great 1.5 mg/dL LVEF least 50 % RVG MUGA No uncontrolled unstable angina No history congestive heart failure cardiac ischemia Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No concurrent active infection serious systemic disorder would preclude study No allergy imidazole compound PRIOR CONCURRENT THERAPY : No prior trastuzumab ( Herceptin ) No concurrent immunotherapy At least 4 week since prior chemotherapy ( 6 week since mitomycin nitrosoureas ) recover No concurrent chemotherapy No concurrent hormonal cancer therapy except LHRH agonist prostate cancer No concurrent radiotherapy No concurrent experimental medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>stage III colon cancer</keyword>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage IV breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>recurrent breast cancer</keyword>
	<keyword>stage III gastric cancer</keyword>
	<keyword>stage IV gastric cancer</keyword>
	<keyword>recurrent gastric cancer</keyword>
	<keyword>occult non-small cell lung cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
	<keyword>recurrent non-small cell lung cancer</keyword>
	<keyword>stage III pancreatic cancer</keyword>
	<keyword>recurrent pancreatic cancer</keyword>
	<keyword>stage III rectal cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
	<keyword>recurrent colon cancer</keyword>
	<keyword>recurrent rectal cancer</keyword>
	<keyword>stage IV anal cancer</keyword>
	<keyword>recurrent anal cancer</keyword>
	<keyword>stage III esophageal cancer</keyword>
	<keyword>stage IV esophageal cancer</keyword>
	<keyword>stage IIIA anal cancer</keyword>
	<keyword>stage IIIB anal cancer</keyword>
	<keyword>recurrent esophageal cancer</keyword>
	<keyword>stage III cervical cancer</keyword>
	<keyword>recurrent cervical cancer</keyword>
	<keyword>stage IVB cervical cancer</keyword>
	<keyword>stage IVA cervical cancer</keyword>
	<keyword>inflammatory breast cancer</keyword>
	<keyword>stage III renal cell cancer</keyword>
	<keyword>stage IV renal cell cancer</keyword>
	<keyword>recurrent renal cell cancer</keyword>
	<keyword>metastatic parathyroid cancer</keyword>
	<keyword>recurrent parathyroid cancer</keyword>
	<keyword>stage III vulvar cancer</keyword>
	<keyword>stage IVB vulvar cancer</keyword>
	<keyword>recurrent vulvar cancer</keyword>
	<keyword>stage III vaginal cancer</keyword>
	<keyword>stage IVA vaginal cancer</keyword>
	<keyword>stage IVB vaginal cancer</keyword>
	<keyword>recurrent vaginal cancer</keyword>
	<keyword>metastatic gastrointestinal carcinoid tumor</keyword>
	<keyword>recurrent gastrointestinal carcinoid tumor</keyword>
	<keyword>localize unresectable adult primary liver cancer</keyword>
	<keyword>advanced adult primary liver cancer</keyword>
	<keyword>recurrent adult primary liver cancer</keyword>
	<keyword>gastrinoma</keyword>
	<keyword>stage III endometrial carcinoma</keyword>
	<keyword>stage IV endometrial carcinoma</keyword>
	<keyword>recurrent endometrial carcinoma</keyword>
	<keyword>small intestine adenocarcinoma</keyword>
	<keyword>unresectable gallbladder cancer</keyword>
	<keyword>recurrent gallbladder cancer</keyword>
	<keyword>unresectable extrahepatic bile duct cancer</keyword>
	<keyword>recurrent extrahepatic bile duct cancer</keyword>
	<keyword>recurrent small intestine cancer</keyword>
	<keyword>stage III adrenocortical carcinoma</keyword>
	<keyword>stage IV adrenocortical carcinoma</keyword>
	<keyword>recurrent adrenocortical carcinoma</keyword>
	<keyword>stage III bladder cancer</keyword>
	<keyword>recurrent bladder cancer</keyword>
	<keyword>stage IV bladder cancer</keyword>
	<keyword>stage III malignant testicular germ cell tumor</keyword>
	<keyword>stage III prostate cancer</keyword>
	<keyword>stage IV prostate cancer</keyword>
	<keyword>recurrent prostate cancer</keyword>
	<keyword>recurrent malignant testicular germ cell tumor</keyword>
	<keyword>insulinoma</keyword>
	<keyword>recurrent islet cell carcinoma</keyword>
	<keyword>stage IV papillary thyroid cancer</keyword>
	<keyword>stage IV follicular thyroid cancer</keyword>
	<keyword>thyroid gland medullary carcinoma</keyword>
	<keyword>anaplastic thyroid cancer</keyword>
	<keyword>recurrent thyroid cancer</keyword>
	<keyword>stage IIIA non-small cell lung cancer</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
	<keyword>stage III salivary gland cancer</keyword>
	<keyword>stage IV salivary gland cancer</keyword>
	<keyword>recurrent salivary gland cancer</keyword>
	<keyword>WDHA syndrome</keyword>
	<keyword>somatostatinoma</keyword>
	<keyword>pancreatic polypeptide tumor</keyword>
	<keyword>glucagonoma</keyword>
	<keyword>stage III follicular thyroid cancer</keyword>
	<keyword>stage III papillary thyroid cancer</keyword>
	<keyword>recurrent urethral cancer</keyword>
	<keyword>distal urethral cancer</keyword>
	<keyword>proximal urethral cancer</keyword>
	<keyword>urethral cancer associate invasive bladder cancer</keyword>
	<keyword>metastatic transitional cell cancer renal pelvis ureter</keyword>
	<keyword>pulmonary carcinoid tumor</keyword>
	<keyword>stage III mucoepidermoid carcinoma oral cavity</keyword>
	<keyword>stage III adenoid cystic carcinoma oral cavity</keyword>
	<keyword>stage IV mucoepidermoid carcinoma oral cavity</keyword>
	<keyword>stage IV adenoid cystic carcinoma oral cavity</keyword>
	<keyword>recurrent mucoepidermoid carcinoma oral cavity</keyword>
	<keyword>recurrent adenoid cystic carcinoma oral cavity</keyword>
	<keyword>tumor metastatic brain</keyword>
	<keyword>lung metastasis</keyword>
	<keyword>liver metastasis</keyword>
	<keyword>bone metastasis</keyword>
	<keyword>skin metastasis</keyword>
	<keyword>leptomeningeal metastasis</keyword>
	<keyword>malignant pericardial effusion</keyword>
	<keyword>malignant pleural effusion</keyword>
	<keyword>newly diagnose carcinoma unknown primary</keyword>
	<keyword>recurrent transitional cell cancer renal pelvis ureter</keyword>
	<keyword>carcinoma appendix</keyword>
	<keyword>primary peritoneal cavity cancer</keyword>
	<keyword>recurrent carcinoma unknown primary</keyword>
	<keyword>male breast cancer</keyword>
	<keyword>stage IV pancreatic cancer</keyword>
</DOC>